rs3823339
Variant names:
Your query was ambiguous. Multiple possible variants found:
Variant summary
Our verdict is Benign. The variant received -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_002116.8(HLA-A):c.1046-43C>A variant causes a intron change involving the alteration of a non-conserved nucleotide. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.0 ( 0 hom., cov: 10)
Exomes 𝑓: 0.0000067 ( 0 hom. )
Failed GnomAD Quality Control
Consequence
HLA-A
NM_002116.8 intron
NM_002116.8 intron
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: -1.13
Publications
11 publications found
Genes affected
HLA-A (HGNC:4931): (major histocompatibility complex, class I, A) HLA-A belongs to the HLA class I heavy chain paralogues. This class I molecule is a heterodimer consisting of a heavy chain and a light chain (beta-2 microglobulin). The heavy chain is anchored in the membrane. Class I molecules play a central role in the immune system by presenting peptides derived from the endoplasmic reticulum lumen so that they can be recognized by cytotoxic T cells. They are expressed in nearly all cells. The heavy chain is approximately 45 kDa and its gene contains 8 exons. Exon 1 encodes the leader peptide, exons 2 and 3 encode the alpha1 and alpha2 domains, which both bind the peptide, exon 4 encodes the alpha3 domain, exon 5 encodes the transmembrane region, and exons 6 and 7 encode the cytoplasmic tail. Polymorphisms within exon 2 and exon 3 are responsible for the peptide binding specificity of each class one molecule. Typing for these polymorphisms is routinely done for bone marrow and kidney transplantation. More than 6000 HLA-A alleles have been described. The HLA system plays an important role in the occurrence and outcome of infectious diseases, including those caused by the malaria parasite, the human immunodeficiency virus (HIV), and the severe acute respiratory syndrome coronavirus (SARS-CoV). The structural spike and the nucleocapsid proteins of the novel coronavirus SARS-CoV-2, which causes coronavirus disease 2019 (COVID-19), are reported to contain multiple Class I epitopes with predicted HLA restrictions. Individual HLA genetic variation may help explain different immune responses to a virus across a population.[provided by RefSeq, Aug 2020]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -8 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.86).
BS2
High AC in GnomAdExome4 at 6 AD gene.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_002116.8. You can select a different transcript below to see updated ACMG assignments.
Ensembl Transcripts
Frequencies
GnomAD3 genomes AF: 0.00 AC: 0AN: 76722Hom.: 0 Cov.: 10
GnomAD3 genomes
AF:
AC:
0
AN:
76722
Hom.:
Cov.:
10
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.00000402 AC: 1AN: 248502 AF XY: 0.00 show subpopulations
GnomAD2 exomes
AF:
AC:
1
AN:
248502
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00000672 AC: 6AN: 893230Hom.: 0 Cov.: 13 AF XY: 0.0000132 AC XY: 6AN XY: 455068 show subpopulations
GnomAD4 exome
AF:
AC:
6
AN:
893230
Hom.:
Cov.:
13
AF XY:
AC XY:
6
AN XY:
455068
show subpopulations
African (AFR)
AF:
AC:
0
AN:
23068
American (AMR)
AF:
AC:
0
AN:
34206
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
16350
East Asian (EAS)
AF:
AC:
0
AN:
25324
South Asian (SAS)
AF:
AC:
0
AN:
64294
European-Finnish (FIN)
AF:
AC:
0
AN:
36508
Middle Eastern (MID)
AF:
AC:
0
AN:
3488
European-Non Finnish (NFE)
AF:
AC:
6
AN:
651100
Other (OTH)
AF:
AC:
0
AN:
38892
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.417
Heterozygous variant carriers
0
1
1
2
2
3
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome Data not reliable, filtered out with message: AC0;AS_VQSR AF: 0.00 AC: 0AN: 76722Hom.: 0 Cov.: 10 AF XY: 0.00 AC XY: 0AN XY: 36992
GnomAD4 genome
Data not reliable, filtered out with message: AC0;AS_VQSR
AF:
AC:
0
AN:
76722
Hom.:
Cov.:
10
AF XY:
AC XY:
0
AN XY:
36992
African (AFR)
AF:
AC:
0
AN:
21270
American (AMR)
AF:
AC:
0
AN:
6166
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
1606
East Asian (EAS)
AF:
AC:
0
AN:
2590
South Asian (SAS)
AF:
AC:
0
AN:
2154
European-Finnish (FIN)
AF:
AC:
0
AN:
5714
Middle Eastern (MID)
AF:
AC:
0
AN:
176
European-Non Finnish (NFE)
AF:
AC:
0
AN:
35566
Other (OTH)
AF:
AC:
0
AN:
1012
Alfa
AF:
Hom.:
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
RBP_binding_hub_radar
RBP_regulation_power_radar
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.